Photocure ASA (0IMT.L)
0IMT.L Stock Price Chart
Explore Photocure ASA interactive price chart. Choose custom timeframes to analyze 0IMT.L price movements and trends.
0IMT.L Company Profile
Discover essential business fundamentals and corporate details for Photocure ASA (0IMT.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
14 Jan 2011
Employees
99.00
Website
https://www.photocure.comCEO
Daniel Schneider
Description
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
0IMT.L Financial Timeline
Browse a chronological timeline of Photocure ASA corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 17 Feb 2026
Upcoming earnings on 29 Oct 2025
Revenue estimate is kr 130.00M.
Earnings released on 30 Jul 2025
EPS came in at -kr 0.06 falling short of the estimated -kr 0.03 by -124.97%, while revenue for the quarter reached kr 135.80M , beating expectations by +3.09%.
Earnings released on 8 May 2025
EPS came in at -kr 0.09 falling short of the estimated -kr 0.04 by -107.71%, while revenue for the quarter reached kr 125.30M , missing expectations by -3.98%.
Earnings released on 19 Feb 2025
EPS came in at -kr 0.21 falling short of the estimated kr 0.21 by -200.00%, while revenue for the quarter reached kr 141.68M , beating expectations by +4.95%.
Earnings released on 13 Nov 2024
EPS came in at -kr 0.13 surpassing the estimated -kr 0.24 by +47.77%, while revenue for the quarter reached kr 120.23M , beating expectations by +2.30%.
Earnings released on 7 Aug 2024
EPS came in at kr 0.45 surpassing the estimated kr 0.30 by +50.40%, while revenue for the quarter reached kr 145.45M , beating expectations by +7.08%.
Earnings released on 15 May 2024
EPS came in at -kr 0.29 falling short of the estimated -kr 0.26 by -10.53%, while revenue for the quarter reached kr 118.03M , beating expectations by +2.55%.
Earnings released on 21 Feb 2024
EPS came in at kr 0.46 surpassing the estimated -kr 0.11 by +501.83%, while revenue for the quarter reached kr 142.55M , beating expectations by +11.73%.
Earnings released on 30 Sept 2023
EPS came in at -kr 0.18 surpassing the estimated -kr 0.43 by +58.57%, while revenue for the quarter reached kr 107.55M , missing expectations by -3.51%.
Earnings released on 30 Jun 2023
EPS came in at kr 0.16 surpassing the estimated -kr 0.30 by +152.39%, while revenue for the quarter reached kr 144.32M , beating expectations by +24.95%.
Earnings released on 31 Mar 2023
EPS came in at -kr 0.43 surpassing the estimated -kr 0.59 by +26.92%, while revenue for the quarter reached kr 106.24M , beating expectations by +1.67%.
Earnings released on 31 Dec 2022
EPS came in at -kr 0.79 falling short of the estimated -kr 0.24 by -229.23%, while revenue for the quarter reached kr 104.19M , missing expectations by -4.75%.
Earnings released on 30 Sept 2022
EPS came in at -kr 0.37 falling short of the estimated -kr 0.17 by -110.20%, while revenue for the quarter reached kr 106.78M , missing expectations by -0.81%.
Earnings released on 30 Jun 2022
EPS came in at -kr 0.68 falling short of the estimated -kr 0.30 by -126.52%, while revenue for the quarter reached kr 100.56M , beating expectations by +0.92%.
Earnings released on 31 Mar 2022
EPS came in at -kr 0.82 falling short of the estimated -kr 0.33 by -147.92%, while revenue for the quarter reached kr 81.60M , missing expectations by -11.05%.
Earnings released on 31 Dec 2021
EPS came in at -kr 1.04 , while revenue for the quarter reached kr 94.52M .
Earnings released on 30 Sept 2021
EPS came in at -kr 0.27 surpassing the estimated -kr 0.27 by +0.98%, while revenue for the quarter reached kr 87.40M , missing expectations by -1.28%.
Earnings released on 30 Jun 2021
EPS came in at -kr 0.39 , while revenue for the quarter reached kr 90.44M .
Earnings released on 31 Mar 2021
EPS came in at kr 0.56 , while revenue for the quarter reached kr 88.18M .
Earnings released on 31 Dec 2020
EPS came in at kr 0.38 , while revenue for the quarter reached kr 97.90M .
Earnings released on 30 Sept 2020
EPS came in at -kr 0.23 , while revenue for the quarter reached kr 49.94M .
0IMT.L Stock Performance
Access detailed 0IMT.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.